Grommes, Christian

Publications

Sort by

Co-Author Network

selected publications

Central Nervous System Lymphoma: Approach to Diagnosis and Treatment. Cancer journal (Sudbury, Mass.). 2020 Review GET IT
Times cited: 8
Comprehensive approach to diagnosis and treatment of newly diagnosed primary CNS lymphoma. Neuro-oncology. 2019 Review GET IT
Times cited: 82
Tracking tumour evolution in glioma through liquid biopsies of cerebrospinal fluid. Nature. 2019 Academic Article GET IT
Times cited: 268
Phase 1b trial of an ibrutinib-based combination therapy in recurrent/refractory CNS lymphoma. Blood. 2018 Academic Article GET IT
Times cited: 123
Phase 1 study of pomalidomide and dexamethasone for relapsed/refractory primary CNS or vitreoretinal lymphoma. Blood. 2018 Academic Article GET IT
Times cited: 72
Pretreatment dynamic contrast-enhanced MRI biomarkers correlate with progression-free survival in primary central nervous system lymphoma. Journal of neuro-oncology. 2018 Academic Article GET IT
Times cited: 13
Treatment of Primary Central Nervous System Lymphoma: From Chemotherapy to Small Molecules. American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting. 2018 Review GET IT
Times cited: 25
The elderly left behind-changes in survival trends of primary central nervous system lymphoma over the past 4 decades. Neuro-oncology. 2018 Academic Article GET IT
Times cited: 117
Updates on Primary Central Nervous System Lymphoma. Current oncology reports. 2018 Review GET IT
Times cited: 31
Retrospective review of safety and efficacy of programmed cell death-1 inhibitors in refractory high grade gliomas. Journal for immunotherapy of cancer. 2017 Academic Article GET IT
Times cited: 34
EGFR feedback-inhibition by Ran-binding protein 6 is disrupted in cancer. Nature communications. 2017 Academic Article GET IT
Times cited: 17
Comparing sequencing assays and human-machine analyses in actionable genomics for glioblastoma. Neurology. Genetics. 2017 Academic Article GET IT
Times cited: 30
Primary CNS Lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2017 Review GET IT
Times cited: 290
Ibrutinib Unmasks Critical Role of Bruton Tyrosine Kinase in Primary CNS Lymphoma. Cancer discovery. 2017 Academic Article GET IT
Times cited: 243
Ibrutinib in PCNSL: The Curious Cases of Clinical Responses and Aspergillosis. Cancer cell. 2017 Comment GET IT
Times cited: 30
Evaluating Cancer of the Central Nervous System Through Next-Generation Sequencing of Cerebrospinal Fluid. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2016 Academic Article GET IT
Times cited: 241
Molecular and Clinical Effects of Notch Inhibition in Glioma Patients: A Phase 0/I Trial. Clinical cancer research : an official journal of the American Association for Cancer Research. 2016 Academic Article GET IT
Times cited: 78
Posterior Reversible Encephalopathy Syndrome in Patients With Cancer. The oncologist. 2015 Academic Article GET IT
Times cited: 67
R-MPV followed by high-dose chemotherapy with TBC and autologous stem-cell transplant for newly diagnosed primary CNS lymphoma. Blood. 2015 Academic Article GET IT
Times cited: 225
Phase II study of bevacizumab, temozolomide, and hypofractionated stereotactic radiotherapy for newly diagnosed glioblastoma. Clinical cancer research : an official journal of the American Association for Cancer Research. 2014 Academic Article GET IT
Times cited: 78
Bevacizumab for the treatment of high-grade glioma: an update after phase III trials. Expert opinion on biological therapy. 2014 Review GET IT
Times cited: 39
Retrospective analysis of the effects of steroid therapy and antidiabetic medication on survival in diabetic glioblastoma patients. CNS oncology. 2013 Academic Article GET IT
Times cited: 25
An inhibitor of mutant IDH1 delays growth and promotes differentiation of glioma cells. Science (New York, N.Y.). 2013 Academic Article GET IT
Times cited: 887
The PPARγ agonist pioglitazone crosses the blood-brain barrier and reduces tumor growth in a human xenograft model. Cancer chemotherapy and pharmacology. 2013 Academic Article GET IT
Times cited: 56
Nervous system metastases from malignant mesothelioma. Clinical oncology (Royal College of Radiologists (Great Britain)). 2012 Letter GET IT
Bevacizumab for the treatment of high-grade glioma. Expert opinion on biological therapy. 2012 Review GET IT
Times cited: 20
Differential sensitivity of glioma- versus lung cancer-specific EGFR mutations to EGFR kinase inhibitors. Cancer discovery. 2012 Academic Article GET IT
Times cited: 246
"Pulsatile" high-dose weekly erlotinib for CNS metastases from EGFR mutant non-small cell lung cancer. Neuro-oncology. 2011 Academic Article GET IT
Times cited: 293
The stepping test: a step back in history. Journal of the history of the neurosciences. 2011 Academic Article GET IT
Times cited: 16
Treatment of epidural spinal cord involvement from germ cell tumors with chemotherapy. Cancer. 2010 Academic Article GET IT
Times cited: 8
Kitten-transmitted Bordetella bronchiseptica infection in a patient receiving temozolomide for glioblastoma. 2010 GET IT
Times cited: 17
Inverse association of PPARγ agonists use and high grade glioma development. Journal of neuro-oncology. 2010 Academic Article GET IT
Times cited: 25
Corpus callosum dysgenesis limits MRI changes to one hemisphere in status epilepticus. Neurology. 2009 Letter GET IT
Corpus callosum dysgenesis limits MRI changes to one hemisphere in status epilepticus. 2009 GET IT
Times cited: 5
Steroid-responsive encephalopathy associated with autoimmune thyroiditis presenting with diffusion MR imaging changes. 2008 GET IT
Times cited: 32
Lambert-Eaton syndrome with large-cell neuroendocrine carcinoma of the lung. 2008 GET IT
Times cited: 9
Cardiac papillary fibroelastoma mimicking left atrial appendage thrombus. 2008 GET IT
Times cited: 2
Regulation of microglial phagocytosis and inflammatory gene expression by Gas6 acting on the Axl/Mer family of tyrosine kinases. Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology. 2007 Academic Article GET IT
Times cited: 115
Inhibition of in vivo glioma growth and invasion by peroxisome proliferator-activated receptor gamma agonist treatment. Molecular pharmacology. 2006 Academic Article GET IT
Times cited: 84
Fibrillar beta-amyloid-stimulated intracellular signaling cascades require Vav for induction of respiratory burst and phagocytosis in monocytes and microglia. The Journal of biological chemistry. 2006 Academic Article GET IT
Times cited: 122
The nonthiazolidinedione tyrosine-based peroxisome proliferator-activated receptor gamma ligand GW7845 induces apoptosis and limits migration and invasion of rat and human glioma cells. The Journal of pharmacology and experimental therapeutics. 2005 Academic Article GET IT
Times cited: 25
Antineoplastic effects of peroxisome proliferator-activated receptor gamma agonists. The Lancet. Oncology. 2004 Review GET IT
Times cited: 409
Different mechanisms of secondary neuronal damage in thalamic nuclei after focal cerebral ischemia in rats. Stroke. 2002 Academic Article GET IT
Times cited: 107
Induction of apoptosis in human and rat glioma by agonists of the nuclear receptor PPARgamma. Journal of neurochemistry. 2002 Academic Article GET IT
Times cited: 126
Retinal ischemia induced by the intraluminal suture method in rats. Neuroscience letters. 1997 Academic Article GET IT
Times cited: 38

more ...

less ...

Background

education and training

M.D., Rheinische-Westfalische Technische Hochschule (Germany) 2000

Contact

full name

Christian Grommes

VIVO Weill Cornell Medical College

Christian Grommes Associate Professor of Neurology

Publications

selected publications

Background

education and training

Contact

full name